N U RSIN G PH ARM AC OL OG Y E XAM IN ATION
ATI Pharmacology
Practice
Version 2 |
60 Questions and Answers with Rationale
Aligned with Current ATI Pharmacology Proctored Exam
Blueprint
Pharmacokinetics, Cardiovascular, Respiratory, Neuro,
Endocrine, Anti-Infectives, Pain, Toxicology
Q UEST I O N S SECT I O N S F O R M AT EDIT IO N
60 8 MCQ LATEST
Q U E S T I O N S A N D A N S W E R S W I T H R AT I O N A L E
,ATI Pharmacology Practice Exam Version 2 | 2026/2027 60 Questions | Version 2
Section 1: Pharmacokinetics and Pharmacodynamics
Q1: A nurse is caring for a client who has a new prescription for nitroglycerin sublingual tablets for angina. The
client asks why the medication cannot be swallowed. Which of the following responses should the nurse make?
A. Swallowing the medication would cause it to be metabolized by the liver before it reaches the
systemic circulation, reducing its effectiveness [CORRECT]
B. The medication is absorbed more slowly when swallowed, delaying relief of chest pain
C. The sublingual route prevents gastrointestinal irritation that occurs with oral administration
D. Swallowing the tablet would result in excessive protein binding, preventing the drug from reaching
cardiac tissue
Correct Answer: A
Rationale: Nitroglycerin undergoes extensive first-pass metabolism in the liver, which would inactivate the majority of the drug
before it reaches systemic circulation. The sublingual route bypasses hepatic metabolism by allowing the drug to enter the
bloodstream directly through the buccal mucosa, providing rapid relief of angina. This is a classic pharmacokinetic application of
route selection to overcome the first-pass effect.
Q2: A nurse is administering medications to a client with chronic liver disease. Which of the following best explains
why the nurse should anticipate an increased effect from orally administered drugs that undergo extensive hepatic
metabolism?
A. Decreased renal clearance leads to drug accumulation
B. Reduced first-pass metabolism increases the bioavailability of the drug [CORRECT]
C. Increased protein binding decreases the amount of free drug available
D. Delayed gastric emptying increases absorption in the small intestine
Correct Answer: B
Rationale: Bioavailability refers to the fraction of an administered drug dose that reaches systemic circulation unchanged. In
clients with chronic liver disease, hepatic first-pass metabolism is impaired, meaning a larger proportion of the drug escapes
inactivation and enters systemic circulation, effectively increasing bioavailability. The nurse should anticipate enhanced drug
effects and monitor for signs of toxicity.
Q3: A client with end-stage renal disease has a serum albumin level of 2.0 g/dL. The provider prescribes warfarin,
which is 99% protein-bound. The nurse should monitor the client for which of the following?
A. Decreased therapeutic effect due to reduced drug absorption
B. Delayed onset of action because of impaired renal clearance
C. Increased risk of bleeding due to higher free (unbound) drug concentration [CORRECT]
D. Reduced risk of adverse effects because less drug reaches tissue receptors
Correct Answer: C
Rationale: Only unbound (free) drug is pharmacologically active and available for distribution to tissues. Hypoalbuminemia
reduces the number of available protein-binding sites, displacing warfarin from albumin and increasing the free drug
concentration. This leads to an enhanced anticoagulant effect and an increased risk of bleeding, requiring close INR monitoring.
Q4: A nurse is reviewing the medication list of a client who takes theophylline for COPD. The client reports eating
large amounts of grapefruit daily. The nurse should expect which of the following changes in theophylline
pharmacokinetics?
ATI Pharmacology Proctored Exam Preparation Page 1
, ATI Pharmacology Practice Exam Version 2 | 2026/2027 60 Questions | Version 2
A. Decreased theophylline half-life due to enzyme induction
B. No change because grapefruit only affects CYP3A4 substrates
C. Increased renal excretion of theophylline
D. Increased theophylline serum levels due to CYP3A4 enzyme inhibition [CORRECT]
Correct Answer: D
Rationale: Grapefruit juice inhibits intestinal CYP3A4 enzymes and P-glycoprotein, reducing presystemic metabolism of drugs
metabolized by this pathway. Theophylline is primarily metabolized by CYP1A2 but also involves CYP3A4 to some extent.
Inhibition of CYP3A4 can lead to decreased drug clearance and elevated serum theophylline levels, increasing the risk of
toxicity. The nurse should advise the client to avoid grapefruit.
Q5: A nurse is preparing to administer a medication with a half-life of 12 hours. The client received a 200 mg dose at
0800. At 2000 the same day, the nurse calculates that approximately how much of the drug remains in the body?
A. 100 mg [CORRECT]
B. 75 mg
C. 50 mg
D. 25 mg
Correct Answer: A
Rationale: The half-life is the time required for the plasma concentration of a drug to decrease by 50%. Since 12 hours have
elapsed (from 0800 to 2000), exactly one half-life has passed. Therefore, 50% of the original 200 mg dose remains, which is 100
mg. This calculation follows first-order kinetics, where a constant fraction of the drug is eliminated per unit time.
Q6: Which of the following best describes a drug with a narrow therapeutic index?
A. The drug has a large margin of safety between the effective dose and the toxic dose
B. The drug has a small margin of safety and requires close serum drug level monitoring
[CORRECT]
C. The drug produces maximal efficacy at very low doses
D. The drug is highly selective for its target receptor and has few side effects
Correct Answer: B
Rationale: The therapeutic index (TI) is the ratio of the toxic dose to the effective dose (TD50/ED50). A narrow therapeutic index
means there is a small difference between a therapeutic dose and a toxic dose, requiring careful dosing and serum drug level
monitoring. Examples include digoxin, warfarin, phenytoin, and theophylline, all of which necessitate close monitoring for
safety.
Q7: A client with opioid use disorder is prescribed buprenorphine as part of medication-assisted treatment. The nurse
explains that buprenorphine acts as a partial agonist at mu-opioid receptors. Which of the following is the most
important clinical implication of this mechanism?
A. Buprenorphine produces a stronger analgesic effect than full opioid agonists
B. Buprenorphine has a higher risk of respiratory depression than morphine
C. Buprenorphine has a ceiling effect on respiratory depression, reducing overdose risk compared
to full agonists [CORRECT]
D. Buprenorphine completely blocks all opioid effects and cannot produce any analgesia
Correct Answer: C
Rationale: A partial agonist binds to a receptor but produces a submaximal response even at full receptor occupancy.
Buprenorphine's partial agonist activity at mu receptors creates a ceiling effect for respiratory depression, meaning higher doses
do not progressively increase this dangerous effect. This makes buprenorphine safer than full opioid agonists in terms of overdose
risk, while still reducing cravings and withdrawal symptoms.
ATI Pharmacology Proctored Exam Preparation Page 2
ATI Pharmacology
Practice
Version 2 |
60 Questions and Answers with Rationale
Aligned with Current ATI Pharmacology Proctored Exam
Blueprint
Pharmacokinetics, Cardiovascular, Respiratory, Neuro,
Endocrine, Anti-Infectives, Pain, Toxicology
Q UEST I O N S SECT I O N S F O R M AT EDIT IO N
60 8 MCQ LATEST
Q U E S T I O N S A N D A N S W E R S W I T H R AT I O N A L E
,ATI Pharmacology Practice Exam Version 2 | 2026/2027 60 Questions | Version 2
Section 1: Pharmacokinetics and Pharmacodynamics
Q1: A nurse is caring for a client who has a new prescription for nitroglycerin sublingual tablets for angina. The
client asks why the medication cannot be swallowed. Which of the following responses should the nurse make?
A. Swallowing the medication would cause it to be metabolized by the liver before it reaches the
systemic circulation, reducing its effectiveness [CORRECT]
B. The medication is absorbed more slowly when swallowed, delaying relief of chest pain
C. The sublingual route prevents gastrointestinal irritation that occurs with oral administration
D. Swallowing the tablet would result in excessive protein binding, preventing the drug from reaching
cardiac tissue
Correct Answer: A
Rationale: Nitroglycerin undergoes extensive first-pass metabolism in the liver, which would inactivate the majority of the drug
before it reaches systemic circulation. The sublingual route bypasses hepatic metabolism by allowing the drug to enter the
bloodstream directly through the buccal mucosa, providing rapid relief of angina. This is a classic pharmacokinetic application of
route selection to overcome the first-pass effect.
Q2: A nurse is administering medications to a client with chronic liver disease. Which of the following best explains
why the nurse should anticipate an increased effect from orally administered drugs that undergo extensive hepatic
metabolism?
A. Decreased renal clearance leads to drug accumulation
B. Reduced first-pass metabolism increases the bioavailability of the drug [CORRECT]
C. Increased protein binding decreases the amount of free drug available
D. Delayed gastric emptying increases absorption in the small intestine
Correct Answer: B
Rationale: Bioavailability refers to the fraction of an administered drug dose that reaches systemic circulation unchanged. In
clients with chronic liver disease, hepatic first-pass metabolism is impaired, meaning a larger proportion of the drug escapes
inactivation and enters systemic circulation, effectively increasing bioavailability. The nurse should anticipate enhanced drug
effects and monitor for signs of toxicity.
Q3: A client with end-stage renal disease has a serum albumin level of 2.0 g/dL. The provider prescribes warfarin,
which is 99% protein-bound. The nurse should monitor the client for which of the following?
A. Decreased therapeutic effect due to reduced drug absorption
B. Delayed onset of action because of impaired renal clearance
C. Increased risk of bleeding due to higher free (unbound) drug concentration [CORRECT]
D. Reduced risk of adverse effects because less drug reaches tissue receptors
Correct Answer: C
Rationale: Only unbound (free) drug is pharmacologically active and available for distribution to tissues. Hypoalbuminemia
reduces the number of available protein-binding sites, displacing warfarin from albumin and increasing the free drug
concentration. This leads to an enhanced anticoagulant effect and an increased risk of bleeding, requiring close INR monitoring.
Q4: A nurse is reviewing the medication list of a client who takes theophylline for COPD. The client reports eating
large amounts of grapefruit daily. The nurse should expect which of the following changes in theophylline
pharmacokinetics?
ATI Pharmacology Proctored Exam Preparation Page 1
, ATI Pharmacology Practice Exam Version 2 | 2026/2027 60 Questions | Version 2
A. Decreased theophylline half-life due to enzyme induction
B. No change because grapefruit only affects CYP3A4 substrates
C. Increased renal excretion of theophylline
D. Increased theophylline serum levels due to CYP3A4 enzyme inhibition [CORRECT]
Correct Answer: D
Rationale: Grapefruit juice inhibits intestinal CYP3A4 enzymes and P-glycoprotein, reducing presystemic metabolism of drugs
metabolized by this pathway. Theophylline is primarily metabolized by CYP1A2 but also involves CYP3A4 to some extent.
Inhibition of CYP3A4 can lead to decreased drug clearance and elevated serum theophylline levels, increasing the risk of
toxicity. The nurse should advise the client to avoid grapefruit.
Q5: A nurse is preparing to administer a medication with a half-life of 12 hours. The client received a 200 mg dose at
0800. At 2000 the same day, the nurse calculates that approximately how much of the drug remains in the body?
A. 100 mg [CORRECT]
B. 75 mg
C. 50 mg
D. 25 mg
Correct Answer: A
Rationale: The half-life is the time required for the plasma concentration of a drug to decrease by 50%. Since 12 hours have
elapsed (from 0800 to 2000), exactly one half-life has passed. Therefore, 50% of the original 200 mg dose remains, which is 100
mg. This calculation follows first-order kinetics, where a constant fraction of the drug is eliminated per unit time.
Q6: Which of the following best describes a drug with a narrow therapeutic index?
A. The drug has a large margin of safety between the effective dose and the toxic dose
B. The drug has a small margin of safety and requires close serum drug level monitoring
[CORRECT]
C. The drug produces maximal efficacy at very low doses
D. The drug is highly selective for its target receptor and has few side effects
Correct Answer: B
Rationale: The therapeutic index (TI) is the ratio of the toxic dose to the effective dose (TD50/ED50). A narrow therapeutic index
means there is a small difference between a therapeutic dose and a toxic dose, requiring careful dosing and serum drug level
monitoring. Examples include digoxin, warfarin, phenytoin, and theophylline, all of which necessitate close monitoring for
safety.
Q7: A client with opioid use disorder is prescribed buprenorphine as part of medication-assisted treatment. The nurse
explains that buprenorphine acts as a partial agonist at mu-opioid receptors. Which of the following is the most
important clinical implication of this mechanism?
A. Buprenorphine produces a stronger analgesic effect than full opioid agonists
B. Buprenorphine has a higher risk of respiratory depression than morphine
C. Buprenorphine has a ceiling effect on respiratory depression, reducing overdose risk compared
to full agonists [CORRECT]
D. Buprenorphine completely blocks all opioid effects and cannot produce any analgesia
Correct Answer: C
Rationale: A partial agonist binds to a receptor but produces a submaximal response even at full receptor occupancy.
Buprenorphine's partial agonist activity at mu receptors creates a ceiling effect for respiratory depression, meaning higher doses
do not progressively increase this dangerous effect. This makes buprenorphine safer than full opioid agonists in terms of overdose
risk, while still reducing cravings and withdrawal symptoms.
ATI Pharmacology Proctored Exam Preparation Page 2
